GlassScriptPhysician profile
Jonathan S Jahr
NPI 1164466652
$222,565.66
in general payments reported to CMS, 2019-2025
9 companies · $55K in 2025
The $55K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105K · 2020: $35K · 2021: $11K · 2022: $4,795 · 2023: $12K · 2024: $545 · 2025: $55K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $49K · Travel and Lodging: $7,679 · Consulting Fee: $5,750 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,815 · Food and Beverage: $1,308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $48,970.00 |
| Travel and Lodging | $7,679.46 |
| Consulting Fee | $5,750.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,815.00 |
| Food and Beverage | $1,308.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $121,083.19 | 2019-2023 | Bridion |
| Octapharma USA, INC. | $55,792.99 | 2019-2025 | Fibryga, Balfaxar |
| Baudax Bio INC. | $21,158.01 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16,300.63 | 2019-2020 | |
| Bayer Healthcare LLC | $5,750.00 | 2023 | |
| Masimo Corporation | $2,274.51 | 2019-2021 | |
| Fresenius Kabi USA, LLC | $83.40 | 2021 | |
| Heron Therapeutics, INC. | $77.51 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $45.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Jahr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.